Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1995-1999  (2)
  • Balancierte Anästhesie  (1)
  • Key words Pertussis  (1)
  • 1
    ISSN: 1432-055X
    Keywords: Schlüsselwörter TIVA ; Propofol/Remifentanil ; Balancierte Anästhesie ; Sevofluran/Fentanyl ; Laparoskopie ; Gynäkologie ; Key words TIVA ; Propofol/Remifentanil ; Balanced anaesthesia ; Sevoflurane/Fentanyl ; Laparoskopy ; Gynaecology
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract Objective: This study was designed to investigate the differences between TIVA with propofol/remifentanil (P/R) and balanced anaesthesia with sevoflurane/fentanyl (S/F) in gynaecological laparoscopic surgery. Emphasis was put on haemodynamic reaction, recovery profile, postoperative side effects and patient satisfaction. Methods: Sixty patients were randomly assigned to receive either total intravenous anaesthesia with propofol/remifentanil or anaesthesia with sevoflurane/fentanyl. After premedication (midazolam) and induction of anesthesia (propofol, atracurium) in both groups, either 1 µg/kg fentanyl (S/F) or 1 µg/kg remifentanil (P/R) was injected. Anaesthesia was maintained with 0.5 µg/kg/min remifentanil (reduced to 50% after 5 min) and 0.06 µg/kg/min propofol (P/R) or 1.7 vol % sevoflurane (S/F). Both groups were mechanically ventilated with 30% oxygen in air. The administration of sevoflurane and the infusion of the anaesthetics were adjusted to maintain a surgical depth of anaesthesia. For postoperative analgesia 1 g paracetamol was administered rectally prior to surgery. After recovery 20 mg/kg metamizol was given intravenously. At the end of surgery the anaesthetics were discontinued and haemodynamics, early emergence from anaesthesia, pain level, frequency of analgesic demand, incidence of PONV, shivering and patient satisfaction were assessed. Parameters were recorded for 24 h postoperatively. Results: Recovery time after propofol-remifentanil anaesthesia was significantly shorter than after administration of sevoflurane and fentanyl (spontaneous ventilation 4.1 vs. 6.3 min, extubation 4.3 vs. 9.3 min, eye opening 4.4 vs 8.2 min, stating name 5.3 vs. 13.2 min, stating date of birth 5.4 vs. 13.3 min). There were no significant differences between the groups in shivering, pain score, analgesic demand and PONV. The S/F group responded to tracheal intubation with significantly higher blood pressure than the P/R group. During maintenance of anaesthesia heart rate in patients with S/F was significantly higher (P/R: HR max +16/–10; S/F: HR max +24/–0.). Measured on a scale from very satisfied to very dissatisfied, 73% of the patients in the P/R group were ”very satisfied” (S/F 23%) and 23% were ”satisfied” (S/F 62%). Conclusion: Compared with patients given balanced anaesthesia with sevoflurane and fentanyl, TIVA with propofol and remifentanil proved to be particularly suited for gynaecological laparoscopic surgery. Its major advantages are haemodynamic stability, significantly shorter times of emergence, and the exceptional acceptance by the patients.
    Notes: Zusammenfassung Fragestellung: Unterscheidet sich eine TIVA mit Remifentanil/Propofol (P/R) von einer balancierten Anästhesie mit Sevofluran/Fentanyl (S/F) hinsichtlich der Hämodynamik, des Aufwachverhaltens, postoperativer Nebenwirkungen und der Patientenzufriedenheit? Methodik: 60 Patientinnen wurden randomisiert einer Anästhesie mit (P/R) oder (S/F) zugeteilt. Nach oraler Prämedikation mit Midazolam wurde die Narkose mit Propofol eingeleitet, die Relaxierung erfolgte mit Atracurium. Gemäß randomisierter Gruppenzuteilung wurde 1 µg/kg Fentanyl oder 1 µg/kg Remifentanil i.v. injiziert und die Narkose bis zum OP-Ende entweder mit 0,5 µg/kg/h Remifentanil (Reduktion auf 50% nach 5 min) und mit 0,06 mg/kg/min Propofol oder mit 1,7 Vol.-% Sevofluran aufrechterhalten. Beide Gruppen wurden mit 30% O2 in Luft beatmet. Die Dosierung von Sevofluran, Propofol und Remifentanil wurden bei Bedarf der jeweiligen Intensität chirurgischer Stimuli angepaßt. Zur postoperativen Analgesie erhielten alle Patientinnen zu OP-Beginn 1 g Paracetamol rektal, nach Erwachen Metamizol 20 mg/kg i.v.. Bei OP-Ende wurde die Anästhetikazufuhr unterbrochen und folgende Parameter erfaßt: mittlerer arterieller Blutdruck, Herzfrequenz, Aufwachverhalten, Schmerzintensität, Analgetikabedarf, PONV, Muskelzittern und die Patientenzufriedenheit mit dem Anästhesieverfahren. Der Beobachtungszeitraum betrug 24 h. Ergebnisse: Die Patientinnen waren nach einer P/R Narkose signifikant eher wach und orientiert als nach einer Anästhesie mit S/F (Spontanatmung 4,1 vs. 6,3 min, Extubation 4,3 vs. 9,3 min, Augenöffnen 4,4 vs. 8,2 min, Namen nennen 5,3 vs. 13,2 min, Geburtsdatum 5,4 vs. 13,3 min). Die Inzidenz von PONV (43% vs. 43%) und Muskelzittern (56% vs. 37%) sowie die Schmerzintensität und die Anzahl der Schmerzmittelanforderungen (67 vs. 52) waren in beiden Gruppen vergleichbar. Der MAP war in der S/F-Gruppe nach der Intubation signifikant höher, die HF im gesamten Verlauf signifikant höher als in der P/R Gruppe (P/R: HF max. +16/–10; S/F: HF max. +24/–0). Auf einer Skala von „sehr zufrieden–sehr unzufrieden” waren 73% (P/R) der Patientinnen mit dem Anästhesieverfahren „sehr zufrieden” (S/F 23%), 23% „zufrieden” (S/F 62%). Schlußfolgerung: Verglichen mit einer balancierten Anästhesie mit Sevofluran und Fentanyl erwies sich die TIVA mit Remifentanil und Propofol als besonders vorteilhaft für laparoskopische Operationen in der Gynäkologie. Wesentliche Vorteile waren signifikant schnellere Aufwachzeiten, die hämodynamische Stabilität und die große Akzeptanz des Anästhesieverfahrens durch die Patientinnen.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    European journal of pediatrics 157 (1998), S. 395-401 
    ISSN: 1432-1076
    Keywords: Key words Pertussis ; Cost-effectiveness ; Acellular pertussis vaccine ; Whole-cell pertussis vaccine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Acellular pertussis vaccines are less reactogenic than whole cell pertussis vaccines, but they are also more expensive. Based on simulation models, we compared the costs and effects of three alternative pertussis vaccination strategies in German children to ”no prevention”: (1) vaccination with whole-cell vaccine at 45% coverage (vaccine efficacy 90%), (2) vaccination with acellular vaccine at 45% coverage (vaccine efficacy 85%), and (3) vaccination with acellular vaccine at 90% coverage. In the two low coverage scenarios expected annual savings in direct medical costs through prevention of disease were larger for whole-cell than for acellular vaccination (252 vs 216 million DM, respectively). Direct costs for treating the more important adverse events induced by whole-cell vaccination (16.9 million DM annually) did not outweigh the higher direct costs of pertussis infections not prevented with the acellular vaccine and the higher price of the acellular vaccine. However, vaccination with acellular pertussis vaccine rapidly becomes as cost saving as vaccination with whole-cell vaccine as soon as vaccination coverage can be raised from 45% to 52.5% with acellular vaccine. Acellular vaccination is also the superior alternative when considering indirect cost savings resulting from reduction in work-loss due to adverse events. Conclusion In our simulations, the most cost-effective pertussis prevention strategy was the use of an effective whole-cell vaccine with a high coverage rate. Introduction of the more expensive acellular pertussis vaccines becomes cost saving if at least a 7.5% increase in coverage is achieved. If also non-medical indirect costs to parents resulting from vaccine associated side-effects are accounted for, acellular vaccines may be more cost-effective also in countries with already high whole-cell vaccine coverage.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...